Inhibition of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation blocks tumor progression in mice

Anticancer Research

Volumn 30, Issue 6, 2010, Pages 1887-1895

  Carine, Nyalendo ^a   Hervé, Sartelet ^b   Denis, Gingras ^a   Richard, Béliveau ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

3D matrix; Antennapedia; MMP 14; MT1 MMP; Tumor progression; Tyrosine phosphorylation

Indexed keywords

ANTENNAPEDIA COUPLED CYTOPLASMIC MATRIX METALLOPROTEINASE 14; ANTENNAPEDIA PROTEIN; ANTINEOPLASTIC AGENT; COLLAGEN TYPE 1; GELATINASE A; MATRIX METALLOPROTEINASE 14; PEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SURVIVAL; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; FIBROSARCOMA; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUNG CARCINOMA; MEDULLOBLASTOMA; MELANOMA; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEINASE INHIBITION; RAT; TUMOR GROWTH; TUMOR NECROSIS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; BIOTIN; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; MATRIX METALLOPROTEINASE 14; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; PHOSPHORYLATION; SARCOMA, EXPERIMENTAL; TYROSINE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77955071865     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Itoh Y and Seiki M: MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 206: 1-8, 2006.
2. Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M and Okada Y: Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am J Pathol 154: 417-428, 1999.
3. Zhai Y, Hotary KB, Nan B, Bosch FX, Munoz N, Weiss SJ and Cho KR: Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Res 65: 6543-6550, 2005.
4. Sabeh F, Ota I, Holmbeck K, Birkedal-Hansen H, Soloway P, Balbin M, Lopez-Otin C, Shapiro S, Inada M, Krane S, Allen E, Chung D and Weiss SJ: Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol 167: 769-781, 2004.
5. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW and Weiss SJ: Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114: 33-45, 2003.
6. Lehti K, Valtanen H, Wickstrom SA, Lohi J and Keski-Oja J: Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J Biol Chem 275: 15006-15013, 2000.
7. Uekita T, Itoh Y, Yana I, Ohno H and Seiki M: Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J Cell Biol 155: 1345-1356, 2001.
8. Langlois S, Gingras D and Beliveau R: Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. Blood 103: 3020-3028, 2004.
9. Gingras D, Bousquet-Gagnon N, Langlois S, Lachambre MP, Annabi B and Beliveau R: Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett 507: 231-236, 2001.
10. Labrecque L, Nyalendo C, Langlois S, Durocher Y, Roghi C, Murphy G, Gingras D and Beliveau R: Src-mediated tyrosine phosphorylation of caveolin-1 induces its association with membrane type 1 matrix metalloproteinase. J Biol Chem 279: 52132-52140, 2004.
11. D'Alessio S, Ferrari G, Cinnante K, Scheerer W, Galloway AC, Roses DF, Rozanov DV, Remacle AG, Oh ES, Shiryaev SA, Strongin AY, Pintucci G and Mignatti P: Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism. J Biol Chem 283: 87-99, 2008.
12. Nyalendo C, Michaud M, Beaulieu E, Roghi C, Murphy G, Gingras D and Beliveau R: Src-dependent phosphorylation of membrane type I matrix metalloproteinase on cytoplasmic tyrosine 573: role in endothelial and tumor cell migration. J Biol Chem 282: 15690-15699, 2007.
13. Gingras D, Michaud M, Di Tomasso G, Beliveau E, Nyalendo C and Beliveau R: Sphingosine-1-phosphate induces the association of membrane-type 1 matrix metalloproteinase with p130Cas in endothelial cells. FEBS Lett 582: 399-404, 2008.
14. Nyalendo C, Beaulieu E, Sartelet H, Michaud M, Fontaine N, Gingras D and Beliveau R: Impaired tyrosine phosphorylation of membrane type 1-matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice. Carcinogenesis 29: 1655-1664, 2008.
15. Chowdhury I, Tharakan B and Bhat GK: Caspases - an update. Comp Biochem Physiol B Biochem Mol Biol 151: 10-27, 2008.
16. Rozanov DV, Deryugina EI, Ratnikov BI, Monosov EZ, Marchenko GN, Quigley JP and Strongin AY: Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells. J Biol Chem 276: 25705-25714, 2001.
17. Hotary K, Allen E, Punturieri A, Yana I and Weiss SJ: Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 149: 1309-1323, 2000.
18. Gingras D and Beliveau R: Emerging concepts in the regulation of membrane-type 1 matrix metalloproteinase activity. Biochim Biophys Acta, 2009.
19. Coussens LM, Fingleton B and Matrisian LM: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392, 2002.
20. Overall CM and Kleifeld O: Tumour microenvironment-opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6: 227-239, 2006.